A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer
Clinical trial NCT01042028 · TERMINATED
Trial details
- NCT number
- NCT01042028
- Sponsor
- Per Pfeiffer
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2012-11-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.